ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.20
-1.16%
S&P ASX All Technology
2,964.10
-1.68%
Brent Oil
85.57
-0.38%
US Dollar vs AUD
1.54533
0.08%
Bitcoin
59,958.89
-1.06%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Stoke Therapeutics Inc (STOK)

  7. Stoke Therapeutics Inc (STOK) News

STOK Stoke Therapeutics Inc

11.03
-0.83 (-7.00%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Stoke Therapeutics Inc STOK NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.83 -7.00% 11.03 09:14:15
Open Price Low Price High Price Close Price Previous Close
11.69 10.98 11.93 11.03 11.86
more quote information »

Recent News

Date Time Source Heading
29/4/202422:00BWStoke Therapeutics Appoints Thomas Leggett as Chief..
17/4/202422:00BWStoke Therapeutics Appoints Jason Hoitt as Chief Commercial..
05/4/202407:30BWStoke Therapeutics to Present at the 23rd Annual Needham..
28/3/202414:40BWStoke Therapeutics Announces Pricing of Upsized $125 Million..
27/3/202407:07BWStoke Therapeutics Announces Proposed Public Offering
26/3/202407:01BWStoke Therapeutics Reports Fourth Quarter and Full Year 2023..
06/3/202408:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202408:28EDGAR2Form 144 - Report of proposed sale of securities
27/2/202402:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
27/2/202402:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/2/202401:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202408:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202408:49EDGAR2Form 144 - Report of proposed sale of securities
18/1/202408:30BWStoke Therapeutics Announces Inducement Grants Under Nasdaq..
09/1/202400:09EDGAR2Form 8-K - Current report
09/1/202400:00BWStoke Therapeutics Highlights Strategic Priorities and..
05/1/202408:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:30BWStoke Therapeutics to Present at the 42nd Annual J.P. Morgan..
03/1/202408:29EDGAR2Form 144 - Report of proposed sale of securities
15/12/202308:05EDGAR2Form 8-K - Current report
06/12/202308:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202308:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202308:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202308:08EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
02/12/202301:04EDGAR2Form 8-K - Current report
02/12/202301:00BWStoke Therapeutics Presents Data From Multiple Studies of..
22/11/202300:00BWStoke Therapeutics to Present Data from the Company’s Dravet..
18/11/202308:37EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
10/11/202308:28EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
08/11/202308:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202323:05EDGAR2Form 8-K - Current report
07/11/202323:00BWStoke Therapeutics Reports Third Quarter Financial Results..
07/11/202308:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/11/202300:01EDGAR2Form SC TO-I - Tender offer statement by Issuer
27/10/202308:00EDGAR2Form 8-K - Current report
18/10/202307:30BWStoke Therapeutics Announces Inducement Grants Under Nasdaq..
29/9/202306:05EDGAR2Form DEF 14A - Other definitive proxy statements
21/9/202322:00BWStoke Therapeutics to Participate in the 2023 Cantor Global..
21/9/202306:37EDGAR2Form 8-K - Current report
21/9/202306:30BWStoke Therapeutics Appoints Ian Smith to its Board of..
19/9/202306:05EDGAR2Form PRE 14A - Other preliminary proxy statements
05/9/202321:00BWStoke Therapeutics Presents Data Related to the Ongoing..
08/8/202306:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202321:05EDGAR2Form 8-K - Current report
07/8/202321:00BWStoke Therapeutics Reports Second Quarter Financial Results..
02/8/202322:00BWStoke Therapeutics to Present at the Canaccord Genuity 43rd..
25/7/202321:05EDGAR2Form 8-K - Current report
25/7/202321:00BWStoke Therapeutics Announces Positive New Safety & Efficacy..
21/7/202321:30BWStoke Therapeutics to Host Webinar to Present New Data from..
07/7/202307:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

NASDAQ
STOK
Stoke Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved